EXAGEN INC. - COMMON S

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 3 2022 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 3 2022 16:05:00 提供 Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 3 2022 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 2 2022 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 1 2022 12:00:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

17 11 2021 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2021 Results

10 11 2021 16:05:01 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

04 11 2021 16:05:01 提供 Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

27 10 2021 16:05:01 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

27 10 2021 08:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Announces $27.2 Million Debt Refinancing

25 10 2021 08:25:00 提供 Nasdaq GlobeNewswire

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

21 10 2021 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

13 9 2021 16:15:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2021 Results

09 8 2021 16:05:01 提供 Nasdaq GlobeNewswire

Exagen Appoints Ana Hooker to Board of Directors

30 7 2021 08:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

29 7 2021 08:25:00 提供 Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021

26 7 2021 16:05:56 提供 Nasdaq GlobeNewswire

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

13 7 2021 16:05:00 提供 Nasdaq GlobeNewswire

Exagen Elects Frank Stokes to Board of Directors

18 6 2021 08:29:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

24 5 2021 16:05:00 提供 Nasdaq GlobeNewswire